Age-related differences in the clinical characteristics of systemic lupus erythematosus in children

Jia Zhu1, Fengqi Wu, Xiaolan Huang

  • 1Division of Pediatric Rheumatology, Children's Hospital Affiliated Capital Institute of Pediatrics, No.2 Yabao Road, Chaoyang District, Beijing 100020, China.

Insights

Pediatric systemic lupus erythematosus (pSLE) presentation varies by age. Preschoolers show shorter disease duration, more neuropsychiatric issues, and poorer outcomes, while adolescents have peak incidence and adult-like characteristics.

Area of Science:

  • Rheumatology
  • Pediatrics
  • Immunology

Background:

  • Systemic lupus erythematosus (SLE) is a chronic autoimmune disease.
  • Pediatric SLE (pSLE) presents unique challenges in diagnosis and management.
  • Understanding age-specific clinical variability is crucial for effective treatment.

Purpose of the Study:

  • To investigate how the clinical presentation of pediatric SLE differs based on age of onset.
  • To compare clinical manifestations, disease activity, and prognosis across different pediatric age groups.

Main Methods:

  • Retrospective chart review of 88 Chinese pediatric SLE patients diagnosed between 2005-2008.
  • Patients categorized into preschool (1-6 yrs), school-age (7-11 yrs), and adolescent (12-18 yrs) groups.
  • Comparison of demographic data, onset symptoms, clinical features, laboratory findings, SLEDAI, and SLICC/ACR SDI.

Main Results:

  • Adolescents comprised the largest group (47.7%).
  • Preschoolers had the shortest disease duration (0.65 ± 0.5 months), highest neuropsychiatric involvement, and poorest prognosis, particularly boys.
  • Common onset symptoms included fever, rash, arthritis, and seizures, with frequent hematologic and neuropsychiatric damage.

Conclusions:

  • Age at onset significantly influences pSLE clinical presentation, disease activity, and prognosis.
  • Preschool-onset pSLE is associated with aggressive disease and poorer outcomes.
  • Adolescent-onset pSLE shows peak incidence and begins to exhibit adult-like characteristics, highlighting the need for age-tailored management strategies.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...